Showing results (1681-1690 of 2,429) with videos related to
Sort By:
Pageof 243
Journal of the American Geriatrics Society|September 8, 2019
Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities StudyStephen P Juraschek, Natalie Daya, Lawrence J Appel, et al.The New England Journal of Medicine|March 14, 2019
Safety and Efficacy of Bempedoic Acid to Reduce LDL CholesterolKausik K Ray, Harold E Bays, Alberico L Catapano, et al.Atherosclerosis|February 1, 2023
Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling projectErnst J Schaefer, Hiroaki Ikezaki, Margaret R Diffenderfer, et al.Memory (Hove, England)|June 14, 2023
Lost in the mall again: a preregistered replication and extension of Loftus & Pickrell (1995)Gillian Murphy, Caroline A Dawson, Charlotte Huston, et al.JACC. Advances|August 5, 2026
Prediabetes, Malignant Left Ventricular Hypertrophy, and Risk of Incident Heart Failure Among Hypertensive AdultsArnaud D Kaze, Stephen P Juraschek, Jordana B Cohen, et al.Plos One|May 15, 2020
Order of same-day concurrent training influences some indices of power development, but not strength, lean mass, or aerobic fitness in healthy, moderately-active men after 9 weeks of trainingMatthew J-C Lee, James K Ballantyne, Javier Chagolla, et al.Diabetes Care|August 31, 2012
Novel risk factors and the prediction of type 2 diabetes in the Atherosclerosis Risk in Communities (ARIC) studyL A Raynor, James S Pankow, Bruce B Duncan, et al.Circulation|February 17, 1999
Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapyC M Ballantyne, J A Herd, L L Ferlic, et al.Journal of Cardiovascular Development and Disease|June 26, 2024
Contrast-Enhanced Magnetic Resonance Imaging Based T1 Mapping and Extracellular Volume Fractions Are Associated with Peripheral Artery DiseaseAsem I Fitian, Michael C Shieh, Olga A Gimnich, et al.American Heart Journal|April 29, 2006
Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) IIChristie M Ballantyne, Marcelo Bertolami, Hugo Ricardo Hernandez Garcia, et al.Pageof 243